| Literature DB >> 2388041 |
A Vink1, P Coulie, G Warnier, J C Renauld, M Stevens, D Donckers, J Van Snick.
Abstract
Murine plasmacytomas show a striking dependence on interleukin 6 (IL-6) for their growth in vitro. Here, we present evidence suggesting that IL-6 also plays an essential role in the in vivo development of these tumors. This conclusion is based on the finding that the tumorigenicity of an IL-6-dependent plasmacytoma cell line was increased approximately 100-fold on transfection with an IL-6 expression vector, whereas it was inhibited in animals treated with monoclonal antibodies capable of blocking the binding of IL-6 to its receptor. Injection of these antibodies 1 d before tumor challenge protected greater than 50% of the mice and retarded tumor growth in all animals. Tumors arising in antibody-treated mice retained their IL-6 dependence in vitro, suggesting that the level of protection could be improved if stronger IL-6 antagonists were available.Entities:
Mesh：
Substances：
Year: 1990 PMID： 2388041 PMCID： PMC2188547 DOI： 10.1084/jem.172.3.997
Source DB: PubMed Journal: J Exp Med ISSN： 0022-1007 Impact factor: 14.307